# Universitäres Kinderwunschzentrum Lübeck

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/universitares-kinderwunschzentrum-lubeck/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74.7 |
| Citations | 50,483 |
| City | Lübeck |
| Country | DE |
| Description | Universitäres Kinderwunschzentrum Lübeck is a research organisation in Lübeck, DE. OpenAlex records 3,495 works and 50,483 citations for it. 947 researchers list it as their most recent affiliation. |
| Homepage | http://www.kinderwunsch-luebeck.de/ |
| OpenAlex ID | https://openalex.org/I4210098936 |
| Researchers | 947 |
| ROR ID | https://ror.org/010mck520 |
| Type | healthcare |
| Works | 3,495 |

## University papers

- [Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer](https://scholariq.org/papers/apalutamide-for-metastatic-castration-sensitive-prostate-cancer/)
- [Mapping and predicting mortality from systemic sclerosis](https://scholariq.org/papers/mapping-and-predicting-mortality-from-systemic-sclerosis/)
- [Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-alone-or-combined-with-chemotherapy-versus-chemotherapy-as-first/)
- [Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study](https://scholariq.org/papers/apalutamide-in-patients-with-metastatic-castration-sensitive-prostate-cancer/)
- [Diagnosis and management of pemphigus: Recommendations of an international panel of experts](https://scholariq.org/papers/diagnosis-and-management-of-pemphigus-recommendations-of-an-international-panel/)
- [Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts](https://scholariq.org/papers/definitions-and-outcome-measures-for-bullous-pemphigoid-recommendations-by-an/)
- [Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database](https://scholariq.org/papers/progressive-interstitial-lung-disease-in-patients-with-systemic-sclerosis/)
- [Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)](https://scholariq.org/papers/updated-s2k-guidelines-on-the-management-of-pemphigus-vulgaris-and-foliaceus/)
- [Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)](https://scholariq.org/papers/updated-scp-s2-scp-k-guidelines-for-the-management-of-bullous-pemphigoid/)
- [S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid](https://scholariq.org/papers/s2k-guideline-for-the-diagnosis-of-pemphigus-vulgaris-foliaceus-and-bullous/)

## University top topics

Showing 8 of 24.

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Health and Medical Studies](https://scholariq.org/topics/health-and-medical-studies/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Aortic Disease and Treatment Approaches](https://scholariq.org/topics/aortic-disease-and-treatment-approaches/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Medical Practices and Rehabilitation](https://scholariq.org/topics/medical-practices-and-rehabilitation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
